1. Friedman DS, Wilson MR, Liebmann JM, et al. An evidencebased assessment of risk factors for the progression of ocular hypertension and glaucoma. Am J Ophthalmol. 2004; 138:S19–31.
Article
2. Cantor LB, Katz LJ, Cheng JW, et al. Economic evaluation of medication, laser trabeculoplasty and filtering surgeries in treating patients with glaucoma in the US. Curr Med Res Opin. 2008; 24:2905–18.
Article
3. Payet S, Denis P, Berdeaux G, et al. Assessment of the cost effectiveness of travoprost versus latanoprost as single agents for treatment of glaucoma in France. Clin Drug Investig. 2008; 28:183–98.
4. Zaninetti M, Ravinet E. Two-year outcomes of selective laser trabeculoplasty in open-angle glaucoma and ocular hypertension. J Fr Ophthalmol. 2008; 31:981–6.
5. Stewart WC, Stewart JA, Mychaskiw MA. Cost-effectiveness of latanoprost and timolol maleate for the treatment of glaucoma in Scandinavia and the United Kingdom, using a decision-analytic health economic model. Eye. 2009; 23:132–40.
Article
6. Lee KW, Park CK, Moon JI. Cost-effectiveness of early surgical or medical therapy for primary open angle glaucoma: a decision ana-lytic model. J Korean Ophthalmol Soc. 2003; 44:1543–50.
7. Kobelt-Nguyen G, Gerdtham UG, Alm A. Costs of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observational two-year chart review of newly diagnosed patients in Sweden and the United States. J Glaucoma. 1998; 7:95–104.
8. Traverso CE, Walt JG, Kelly SP, et al. Direct costs of glaucoma and severity of the disease: a multinational long term study of re-source utilisation in Europe. Br J Ophthalmol. 2005; 89:1245–9.
Article
9. Moon SC, Rho SH, Ahn HB. The clinical effect of trabeculectomy. J Korean Ophthalmol Soc. 1997; 38:839–48.
10. Nouri-Mahdavi K, Brigatti L, Weitzman M, Caprioli J. Outcomes of trabeculectomy for primary open-angle glaucoma. Ophthalmology. 1995; 102:1760–9.
Article
11. Feiner L, Piltz-Seymour JR. Collaborative Initial Glaucoma Treatment Study. Collaborative Initial Glaucoma Treatment Study: a summary of results to date. Curr Opin Ophthalmol. 2003; 14:106–11.
12. Migdal C, Gregory W, Hitchings R. Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology. 1994; 101:1651–6.
Article
13. Shirato S, Kitazawa Y, Mishima S. A critical analysis of the trabeculectomy results by a prospective follow-up design. Jpn J Ophthalmol. 1982; 26:468–80.
14. Park MH, Moon JI. Selective laser trabeculoplasty in fertile women with open angle glaucoma or ocular hypertension. J Korean Ophthalmol Soc. 2007; 48:1494–9.
Article
15. Latina MA, Sibayan SA, Shin DH, et al. Q-switched 532-nm Nd:YAG laser trabeculoplasty (selective laser trabeculoplasty): a multicenter, pilot, clinical study. Ophthalmology. 1998; 105:2082–8.
16. Kano K, Kuwayama Y, Mizoue S, Ito N. Clinical results of selective laser trabeculoplasty. Nippon Ganka Gakkai Zasshi. 1999; 103:612–13.
Article
17. Gracner T, Pahor D, Gracner B. Efficacy of selective laser trabeculoplasty in the treatment of primary open-angle glaucoma. Klin Monbl Augenheilkd. 2003; 220:848–52.
18. McIlraith I, Strasfeld M, Colev G, Hutnik CM. Selective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucoma. J Glaucoma. 2006; 15:124–30.
Article
19. Melamed S, Ben Simon GJ, Levkovitch-Verbin H. Selective laser trabeculoplasty as primary treatment for open-angle glaucoma: a prospective, nonrandomized pilot study. Arch Ophthalmol. 2003; 121:957–60.
20. Juzych MS, Chopra V, Banitt MR, et al. Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma. Ophthalmology. 2004; 111:1853–9.
Article
21. Lai JS, Chua JK, Tham CC, Lam DS. Five-year follow up of selective laser trabeculoplasty in Chinese eyes. Clin Experiment Ophthalmol. 2004; 32:368–72.
Article
22. Buys YM. Economics of selective laser trabeculoplasty as primary therapy for glaucoma. Can J Ophthalmol. 2006; 41:419–20.
Article
23. Damji KF, Bovell AM, Hodge WG, et al. Selective laser trabeculoplasty versus argon laser trabeculoplasty: results from a 1-year randomised clinical trial. Br J Ophthalmol. 2006; 90:1490–4.
Article
24. Knox FA, Barry M, McGowan B, O’Brien C. The rising cost of glaucoma drugs in Ireland 1996-2003. Br J Ophthalmol. 2006; 90:162–5.
Article
25. Oba Y. Cost-effectiveness of salmeterol, fluticasone, and combination therapy for COPD. Am J Manag Care. 2009; 15:226–32.
26. Wu JM, Siddiqui NY, Amundsen CL, et al. Cost-effectiveness of botulinum toxin A versus anticholinergic medications for idiopathic urge incontinence. J Urol. 2009; 181:2181–6.
Article
27. Rowe AJ, Meneghetti AT, Schumacher PA, et al. Perioperative analysis of laparoscopic versus open liver resection. Surg Endosc. 2009; 23:1198–203.
Article
28. Tilney HS, Lovegrove RE, Purkayastha S, et al. Comparison of colonic stenting and open surgery for malignant large bowel obstruction. Surg Endosc. 2007; 21:225–33.
Article
29. Goodnough LT, Despotis GJ, Merkel K, Monk TG. A randomized trial comparing acute normovolemic hemodilution and pre-operative autologous blood donation in total hip arthroplasty. Transfusion. 2000; 40:1054–7.
Article